Tirzepatide

Tirzepatide is a prescription medication that acts on two gut-derived hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). It improves blood sugar control by increasing insulin secretion when glucose is high, reducing glucagon release, slowing gastric emptying, and promoting feelings of fullness. It is used primarily to treat type 2 diabetes and, in some formulations and dosing strategies, to support weight management under medical supervision.

We offer tirzepatide through a monthly prescribed subscription service. This includes:

• A clinician review to determine if tirzepatide is appropriate for you.

• Ongoing medical oversight with prescription management.

• Monthly deliveries of medication as prescribed.

• We do not require Blood work, save time and money

• Support for questions about dosing, side effects, and monitoring.

Important considerations:

• Tirzepatide is prescription-only and must be started under a clinician’s guidance.

• Common side effects include nausea, vomiting, diarrhea, constipation, and decreased appetite. Serious but less common risks include pancreatitis, gallbladder disease, and potential thyroid C-cell tumors in rodent studies; discuss personal risk factors with your clinician.

• It may interact with other medications and affect blood sugar levels, especially if you use insulin or sulfonylureas.

• Regular monitoring (blood glucose, renal function, and other tests as recommended) is required.

To learn more or begin the subscription process, contact our mobile division and speak with our Nurse Madeline Santucci to set up a Free Consultaion 239-263-9043 or speak with the owner Mike Minichiello 954-729-8536